Hormone therapy in the management of prostate cancer: evidence-based approaches
about
Management of high-risk localized prostate cancer.New considerations for ADT in advanced prostate cancer and the emerging role of GnRH antagonists.From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer.Findings from the Initial Use of the Healthy Homes Rating System (HHRS) in Three American Cities.miR-30e* is overexpressed in prostate cancer and promotes NF-κB-mediated proliferation and tumor growth.Is the detection rate of 18F-choline PET/CT influenced by androgen-deprivation therapy?
P2860
Hormone therapy in the management of prostate cancer: evidence-based approaches
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Hormone therapy in the management of prostate cancer: evidence-based approaches
@ast
Hormone therapy in the management of prostate cancer: evidence-based approaches
@en
type
label
Hormone therapy in the management of prostate cancer: evidence-based approaches
@ast
Hormone therapy in the management of prostate cancer: evidence-based approaches
@en
prefLabel
Hormone therapy in the management of prostate cancer: evidence-based approaches
@ast
Hormone therapy in the management of prostate cancer: evidence-based approaches
@en
P2093
P2860
P356
P1476
Hormone therapy in the management of prostate cancer: evidence-based approaches
@en
P2093
Costas Lallas
Jaspreet Singh
Leonard G Gomella
P2860
P304
P356
10.1177/1756287210375270
P577
2010-08-01T00:00:00Z